Pharma & Healthcare
Global Terbinafine Hydrochloride Drug Market Research Report 2024
- Jan 18, 24
- ID: 3140
- Pages: 103
- Figures: 231
- Views: 20
Terbinafine, sold under the brand name Lamisil among others, an antifungal medication used to treat pityriasis versicolor, fungal nail infections, and ringworm including jock itch and athlete's foot. It is either taken by mouth or applied to the skin as a cream or ointment. The cream and ointment are not effective for nail infections.
The global Terbinafine Hydrochloride Drug market was valued at US$ 614 million in 2023 and is anticipated to reach US$ 912.6 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Terbinafine Hydrochloride Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terbinafine Hydrochloride Drug.
Report Scope
The Terbinafine Hydrochloride Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Terbinafine Hydrochloride Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Terbinafine Hydrochloride Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
GSK
TEVA
Dr. Reddy's Laboratories
CIPLA LTD
TARO
InvaGen Pharmaceuticals
Breckenridge Pharmaceutical
Harris Pharmaceutical
Glenmark
Orchid Healthcare
APOTEX
Jilin Wantong Group
Cussess
Hubei Hengan Fulin Pharm
Xiuzheng Pharmaceutical
Segment by Type
Topical
Oral
Segment by Application
Fingernail Infection
Toenail Infection
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Terbinafine Hydrochloride Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Terbinafine Hydrochloride Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Terbinafine Hydrochloride Drug market was valued at US$ 614 million in 2023 and is anticipated to reach US$ 912.6 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Terbinafine Hydrochloride Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terbinafine Hydrochloride Drug.
Report Scope
The Terbinafine Hydrochloride Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Terbinafine Hydrochloride Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Terbinafine Hydrochloride Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
GSK
TEVA
Dr. Reddy's Laboratories
CIPLA LTD
TARO
InvaGen Pharmaceuticals
Breckenridge Pharmaceutical
Harris Pharmaceutical
Glenmark
Orchid Healthcare
APOTEX
Jilin Wantong Group
Cussess
Hubei Hengan Fulin Pharm
Xiuzheng Pharmaceutical
Segment by Type
Topical
Oral
Segment by Application
Fingernail Infection
Toenail Infection
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Terbinafine Hydrochloride Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Terbinafine Hydrochloride Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Terbinafine Hydrochloride Drug Market Overview
1.1 Product Overview and Scope of Terbinafine Hydrochloride Drug
1.2 Terbinafine Hydrochloride Drug Segment by Type
1.2.1 Global Terbinafine Hydrochloride Drug Market Value Comparison by Type (2024-2030)
1.2.2 Topical
1.2.3 Oral
1.3 Terbinafine Hydrochloride Drug Segment by Application
1.3.1 Global Terbinafine Hydrochloride Drug Market Value by Application: (2024-2030)
1.3.2 Fingernail Infection
1.3.3 Toenail Infection
1.3.4 Others
1.4 Global Terbinafine Hydrochloride Drug Market Size Estimates and Forecasts
1.4.1 Global Terbinafine Hydrochloride Drug Revenue 2019-2030
1.4.2 Global Terbinafine Hydrochloride Drug Sales 2019-2030
1.4.3 Global Terbinafine Hydrochloride Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Terbinafine Hydrochloride Drug Market Competition by Manufacturers
2.1 Global Terbinafine Hydrochloride Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Terbinafine Hydrochloride Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Terbinafine Hydrochloride Drug Average Price by Manufacturers (2019-2024)
2.4 Global Terbinafine Hydrochloride Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Terbinafine Hydrochloride Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Terbinafine Hydrochloride Drug, Product Type & Application
2.7 Terbinafine Hydrochloride Drug Market Competitive Situation and Trends
2.7.1 Terbinafine Hydrochloride Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Terbinafine Hydrochloride Drug Players Market Share by Revenue
2.7.3 Global Terbinafine Hydrochloride Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Terbinafine Hydrochloride Drug Retrospective Market Scenario by Region
3.1 Global Terbinafine Hydrochloride Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Terbinafine Hydrochloride Drug Global Terbinafine Hydrochloride Drug Sales by Region: 2019-2030
3.2.1 Global Terbinafine Hydrochloride Drug Sales by Region: 2019-2024
3.2.2 Global Terbinafine Hydrochloride Drug Sales by Region: 2025-2030
3.3 Global Terbinafine Hydrochloride Drug Global Terbinafine Hydrochloride Drug Revenue by Region: 2019-2030
3.3.1 Global Terbinafine Hydrochloride Drug Revenue by Region: 2019-2024
3.3.2 Global Terbinafine Hydrochloride Drug Revenue by Region: 2025-2030
3.4 North America Terbinafine Hydrochloride Drug Market Facts & Figures by Country
3.4.1 North America Terbinafine Hydrochloride Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Terbinafine Hydrochloride Drug Sales by Country (2019-2030)
3.4.3 North America Terbinafine Hydrochloride Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Terbinafine Hydrochloride Drug Market Facts & Figures by Country
3.5.1 Europe Terbinafine Hydrochloride Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Terbinafine Hydrochloride Drug Sales by Country (2019-2030)
3.5.3 Europe Terbinafine Hydrochloride Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Terbinafine Hydrochloride Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Terbinafine Hydrochloride Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Terbinafine Hydrochloride Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Terbinafine Hydrochloride Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Terbinafine Hydrochloride Drug Market Facts & Figures by Country
3.7.1 Latin America Terbinafine Hydrochloride Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Terbinafine Hydrochloride Drug Sales by Country (2019-2030)
3.7.3 Latin America Terbinafine Hydrochloride Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Terbinafine Hydrochloride Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Terbinafine Hydrochloride Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Terbinafine Hydrochloride Drug Sales by Type (2019-2030)
4.1.1 Global Terbinafine Hydrochloride Drug Sales by Type (2019-2024)
4.1.2 Global Terbinafine Hydrochloride Drug Sales by Type (2025-2030)
4.1.3 Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2019-2030)
4.2 Global Terbinafine Hydrochloride Drug Revenue by Type (2019-2030)
4.2.1 Global Terbinafine Hydrochloride Drug Revenue by Type (2019-2024)
4.2.2 Global Terbinafine Hydrochloride Drug Revenue by Type (2025-2030)
4.2.3 Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2019-2030)
4.3 Global Terbinafine Hydrochloride Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Terbinafine Hydrochloride Drug Sales by Application (2019-2030)
5.1.1 Global Terbinafine Hydrochloride Drug Sales by Application (2019-2024)
5.1.2 Global Terbinafine Hydrochloride Drug Sales by Application (2025-2030)
5.1.3 Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2019-2030)
5.2 Global Terbinafine Hydrochloride Drug Revenue by Application (2019-2030)
5.2.1 Global Terbinafine Hydrochloride Drug Revenue by Application (2019-2024)
5.2.2 Global Terbinafine Hydrochloride Drug Revenue by Application (2025-2030)
5.2.3 Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2019-2030)
5.3 Global Terbinafine Hydrochloride Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Terbinafine Hydrochloride Drug Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Terbinafine Hydrochloride Drug Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Corporation Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TEVA Terbinafine Hydrochloride Drug Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Dr. Reddy's Laboratories
6.4.1 Dr. Reddy's Laboratories Corporation Information
6.4.2 Dr. Reddy's Laboratories Description and Business Overview
6.4.3 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Portfolio
6.4.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.5 CIPLA LTD
6.5.1 CIPLA LTD Corporation Information
6.5.2 CIPLA LTD Description and Business Overview
6.5.3 CIPLA LTD Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CIPLA LTD Terbinafine Hydrochloride Drug Product Portfolio
6.5.5 CIPLA LTD Recent Developments/Updates
6.6 TARO
6.6.1 TARO Corporation Information
6.6.2 TARO Description and Business Overview
6.6.3 TARO Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 TARO Terbinafine Hydrochloride Drug Product Portfolio
6.6.5 TARO Recent Developments/Updates
6.7 InvaGen Pharmaceuticals
6.6.1 InvaGen Pharmaceuticals Corporation Information
6.6.2 InvaGen Pharmaceuticals Description and Business Overview
6.6.3 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Portfolio
6.7.5 InvaGen Pharmaceuticals Recent Developments/Updates
6.8 Breckenridge Pharmaceutical
6.8.1 Breckenridge Pharmaceutical Corporation Information
6.8.2 Breckenridge Pharmaceutical Description and Business Overview
6.8.3 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
6.8.5 Breckenridge Pharmaceutical Recent Developments/Updates
6.9 Harris Pharmaceutical
6.9.1 Harris Pharmaceutical Corporation Information
6.9.2 Harris Pharmaceutical Description and Business Overview
6.9.3 Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
6.9.5 Harris Pharmaceutical Recent Developments/Updates
6.10 Glenmark
6.10.1 Glenmark Corporation Information
6.10.2 Glenmark Description and Business Overview
6.10.3 Glenmark Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Glenmark Terbinafine Hydrochloride Drug Product Portfolio
6.10.5 Glenmark Recent Developments/Updates
6.11 Orchid Healthcare
6.11.1 Orchid Healthcare Corporation Information
6.11.2 Orchid Healthcare Terbinafine Hydrochloride Drug Description and Business Overview
6.11.3 Orchid Healthcare Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Orchid Healthcare Terbinafine Hydrochloride Drug Product Portfolio
6.11.5 Orchid Healthcare Recent Developments/Updates
6.12 APOTEX
6.12.1 APOTEX Corporation Information
6.12.2 APOTEX Terbinafine Hydrochloride Drug Description and Business Overview
6.12.3 APOTEX Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 APOTEX Terbinafine Hydrochloride Drug Product Portfolio
6.12.5 APOTEX Recent Developments/Updates
6.13 Jilin Wantong Group
6.13.1 Jilin Wantong Group Corporation Information
6.13.2 Jilin Wantong Group Terbinafine Hydrochloride Drug Description and Business Overview
6.13.3 Jilin Wantong Group Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jilin Wantong Group Terbinafine Hydrochloride Drug Product Portfolio
6.13.5 Jilin Wantong Group Recent Developments/Updates
6.14 Cussess
6.14.1 Cussess Corporation Information
6.14.2 Cussess Terbinafine Hydrochloride Drug Description and Business Overview
6.14.3 Cussess Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Cussess Terbinafine Hydrochloride Drug Product Portfolio
6.14.5 Cussess Recent Developments/Updates
6.15 Hubei Hengan Fulin Pharm
6.15.1 Hubei Hengan Fulin Pharm Corporation Information
6.15.2 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Description and Business Overview
6.15.3 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Portfolio
6.15.5 Hubei Hengan Fulin Pharm Recent Developments/Updates
6.16 Xiuzheng Pharmaceutical
6.16.1 Xiuzheng Pharmaceutical Corporation Information
6.16.2 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Description and Business Overview
6.16.3 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
6.16.5 Xiuzheng Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Terbinafine Hydrochloride Drug Industry Chain Analysis
7.2 Terbinafine Hydrochloride Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Terbinafine Hydrochloride Drug Production Mode & Process
7.4 Terbinafine Hydrochloride Drug Sales and Marketing
7.4.1 Terbinafine Hydrochloride Drug Sales Channels
7.4.2 Terbinafine Hydrochloride Drug Distributors
7.5 Terbinafine Hydrochloride Drug Customers
8 Terbinafine Hydrochloride Drug Market Dynamics
8.1 Terbinafine Hydrochloride Drug Industry Trends
8.2 Terbinafine Hydrochloride Drug Market Drivers
8.3 Terbinafine Hydrochloride Drug Market Challenges
8.4 Terbinafine Hydrochloride Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Terbinafine Hydrochloride Drug
1.2 Terbinafine Hydrochloride Drug Segment by Type
1.2.1 Global Terbinafine Hydrochloride Drug Market Value Comparison by Type (2024-2030)
1.2.2 Topical
1.2.3 Oral
1.3 Terbinafine Hydrochloride Drug Segment by Application
1.3.1 Global Terbinafine Hydrochloride Drug Market Value by Application: (2024-2030)
1.3.2 Fingernail Infection
1.3.3 Toenail Infection
1.3.4 Others
1.4 Global Terbinafine Hydrochloride Drug Market Size Estimates and Forecasts
1.4.1 Global Terbinafine Hydrochloride Drug Revenue 2019-2030
1.4.2 Global Terbinafine Hydrochloride Drug Sales 2019-2030
1.4.3 Global Terbinafine Hydrochloride Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Terbinafine Hydrochloride Drug Market Competition by Manufacturers
2.1 Global Terbinafine Hydrochloride Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Terbinafine Hydrochloride Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Terbinafine Hydrochloride Drug Average Price by Manufacturers (2019-2024)
2.4 Global Terbinafine Hydrochloride Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Terbinafine Hydrochloride Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Terbinafine Hydrochloride Drug, Product Type & Application
2.7 Terbinafine Hydrochloride Drug Market Competitive Situation and Trends
2.7.1 Terbinafine Hydrochloride Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Terbinafine Hydrochloride Drug Players Market Share by Revenue
2.7.3 Global Terbinafine Hydrochloride Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Terbinafine Hydrochloride Drug Retrospective Market Scenario by Region
3.1 Global Terbinafine Hydrochloride Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Terbinafine Hydrochloride Drug Global Terbinafine Hydrochloride Drug Sales by Region: 2019-2030
3.2.1 Global Terbinafine Hydrochloride Drug Sales by Region: 2019-2024
3.2.2 Global Terbinafine Hydrochloride Drug Sales by Region: 2025-2030
3.3 Global Terbinafine Hydrochloride Drug Global Terbinafine Hydrochloride Drug Revenue by Region: 2019-2030
3.3.1 Global Terbinafine Hydrochloride Drug Revenue by Region: 2019-2024
3.3.2 Global Terbinafine Hydrochloride Drug Revenue by Region: 2025-2030
3.4 North America Terbinafine Hydrochloride Drug Market Facts & Figures by Country
3.4.1 North America Terbinafine Hydrochloride Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Terbinafine Hydrochloride Drug Sales by Country (2019-2030)
3.4.3 North America Terbinafine Hydrochloride Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Terbinafine Hydrochloride Drug Market Facts & Figures by Country
3.5.1 Europe Terbinafine Hydrochloride Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Terbinafine Hydrochloride Drug Sales by Country (2019-2030)
3.5.3 Europe Terbinafine Hydrochloride Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Terbinafine Hydrochloride Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Terbinafine Hydrochloride Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Terbinafine Hydrochloride Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Terbinafine Hydrochloride Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Terbinafine Hydrochloride Drug Market Facts & Figures by Country
3.7.1 Latin America Terbinafine Hydrochloride Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Terbinafine Hydrochloride Drug Sales by Country (2019-2030)
3.7.3 Latin America Terbinafine Hydrochloride Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Terbinafine Hydrochloride Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Terbinafine Hydrochloride Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Terbinafine Hydrochloride Drug Sales by Type (2019-2030)
4.1.1 Global Terbinafine Hydrochloride Drug Sales by Type (2019-2024)
4.1.2 Global Terbinafine Hydrochloride Drug Sales by Type (2025-2030)
4.1.3 Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2019-2030)
4.2 Global Terbinafine Hydrochloride Drug Revenue by Type (2019-2030)
4.2.1 Global Terbinafine Hydrochloride Drug Revenue by Type (2019-2024)
4.2.2 Global Terbinafine Hydrochloride Drug Revenue by Type (2025-2030)
4.2.3 Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2019-2030)
4.3 Global Terbinafine Hydrochloride Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Terbinafine Hydrochloride Drug Sales by Application (2019-2030)
5.1.1 Global Terbinafine Hydrochloride Drug Sales by Application (2019-2024)
5.1.2 Global Terbinafine Hydrochloride Drug Sales by Application (2025-2030)
5.1.3 Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2019-2030)
5.2 Global Terbinafine Hydrochloride Drug Revenue by Application (2019-2030)
5.2.1 Global Terbinafine Hydrochloride Drug Revenue by Application (2019-2024)
5.2.2 Global Terbinafine Hydrochloride Drug Revenue by Application (2025-2030)
5.2.3 Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2019-2030)
5.3 Global Terbinafine Hydrochloride Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Terbinafine Hydrochloride Drug Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Terbinafine Hydrochloride Drug Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Corporation Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TEVA Terbinafine Hydrochloride Drug Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Dr. Reddy's Laboratories
6.4.1 Dr. Reddy's Laboratories Corporation Information
6.4.2 Dr. Reddy's Laboratories Description and Business Overview
6.4.3 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Portfolio
6.4.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.5 CIPLA LTD
6.5.1 CIPLA LTD Corporation Information
6.5.2 CIPLA LTD Description and Business Overview
6.5.3 CIPLA LTD Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CIPLA LTD Terbinafine Hydrochloride Drug Product Portfolio
6.5.5 CIPLA LTD Recent Developments/Updates
6.6 TARO
6.6.1 TARO Corporation Information
6.6.2 TARO Description and Business Overview
6.6.3 TARO Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 TARO Terbinafine Hydrochloride Drug Product Portfolio
6.6.5 TARO Recent Developments/Updates
6.7 InvaGen Pharmaceuticals
6.6.1 InvaGen Pharmaceuticals Corporation Information
6.6.2 InvaGen Pharmaceuticals Description and Business Overview
6.6.3 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Portfolio
6.7.5 InvaGen Pharmaceuticals Recent Developments/Updates
6.8 Breckenridge Pharmaceutical
6.8.1 Breckenridge Pharmaceutical Corporation Information
6.8.2 Breckenridge Pharmaceutical Description and Business Overview
6.8.3 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
6.8.5 Breckenridge Pharmaceutical Recent Developments/Updates
6.9 Harris Pharmaceutical
6.9.1 Harris Pharmaceutical Corporation Information
6.9.2 Harris Pharmaceutical Description and Business Overview
6.9.3 Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
6.9.5 Harris Pharmaceutical Recent Developments/Updates
6.10 Glenmark
6.10.1 Glenmark Corporation Information
6.10.2 Glenmark Description and Business Overview
6.10.3 Glenmark Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Glenmark Terbinafine Hydrochloride Drug Product Portfolio
6.10.5 Glenmark Recent Developments/Updates
6.11 Orchid Healthcare
6.11.1 Orchid Healthcare Corporation Information
6.11.2 Orchid Healthcare Terbinafine Hydrochloride Drug Description and Business Overview
6.11.3 Orchid Healthcare Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Orchid Healthcare Terbinafine Hydrochloride Drug Product Portfolio
6.11.5 Orchid Healthcare Recent Developments/Updates
6.12 APOTEX
6.12.1 APOTEX Corporation Information
6.12.2 APOTEX Terbinafine Hydrochloride Drug Description and Business Overview
6.12.3 APOTEX Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 APOTEX Terbinafine Hydrochloride Drug Product Portfolio
6.12.5 APOTEX Recent Developments/Updates
6.13 Jilin Wantong Group
6.13.1 Jilin Wantong Group Corporation Information
6.13.2 Jilin Wantong Group Terbinafine Hydrochloride Drug Description and Business Overview
6.13.3 Jilin Wantong Group Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jilin Wantong Group Terbinafine Hydrochloride Drug Product Portfolio
6.13.5 Jilin Wantong Group Recent Developments/Updates
6.14 Cussess
6.14.1 Cussess Corporation Information
6.14.2 Cussess Terbinafine Hydrochloride Drug Description and Business Overview
6.14.3 Cussess Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Cussess Terbinafine Hydrochloride Drug Product Portfolio
6.14.5 Cussess Recent Developments/Updates
6.15 Hubei Hengan Fulin Pharm
6.15.1 Hubei Hengan Fulin Pharm Corporation Information
6.15.2 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Description and Business Overview
6.15.3 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Portfolio
6.15.5 Hubei Hengan Fulin Pharm Recent Developments/Updates
6.16 Xiuzheng Pharmaceutical
6.16.1 Xiuzheng Pharmaceutical Corporation Information
6.16.2 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Description and Business Overview
6.16.3 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
6.16.5 Xiuzheng Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Terbinafine Hydrochloride Drug Industry Chain Analysis
7.2 Terbinafine Hydrochloride Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Terbinafine Hydrochloride Drug Production Mode & Process
7.4 Terbinafine Hydrochloride Drug Sales and Marketing
7.4.1 Terbinafine Hydrochloride Drug Sales Channels
7.4.2 Terbinafine Hydrochloride Drug Distributors
7.5 Terbinafine Hydrochloride Drug Customers
8 Terbinafine Hydrochloride Drug Market Dynamics
8.1 Terbinafine Hydrochloride Drug Industry Trends
8.2 Terbinafine Hydrochloride Drug Market Drivers
8.3 Terbinafine Hydrochloride Drug Market Challenges
8.4 Terbinafine Hydrochloride Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Terbinafine Hydrochloride Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Terbinafine Hydrochloride Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Terbinafine Hydrochloride Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Terbinafine Hydrochloride Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Terbinafine Hydrochloride Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Terbinafine Hydrochloride Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Terbinafine Hydrochloride Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Terbinafine Hydrochloride Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Terbinafine Hydrochloride Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Terbinafine Hydrochloride Drug, Product Type & Application
Table 12. Global Key Manufacturers of Terbinafine Hydrochloride Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Terbinafine Hydrochloride Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Terbinafine Hydrochloride Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Terbinafine Hydrochloride Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Terbinafine Hydrochloride Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2019-2024)
Table 19. Global Terbinafine Hydrochloride Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2025-2030)
Table 21. Global Terbinafine Hydrochloride Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Terbinafine Hydrochloride Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Terbinafine Hydrochloride Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Terbinafine Hydrochloride Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Terbinafine Hydrochloride Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Terbinafine Hydrochloride Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Terbinafine Hydrochloride Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Terbinafine Hydrochloride Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Terbinafine Hydrochloride Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Terbinafine Hydrochloride Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Terbinafine Hydrochloride Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Terbinafine Hydrochloride Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Terbinafine Hydrochloride Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Terbinafine Hydrochloride Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Terbinafine Hydrochloride Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Terbinafine Hydrochloride Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Terbinafine Hydrochloride Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Terbinafine Hydrochloride Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Terbinafine Hydrochloride Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Terbinafine Hydrochloride Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Terbinafine Hydrochloride Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Terbinafine Hydrochloride Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Terbinafine Hydrochloride Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Terbinafine Hydrochloride Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Terbinafine Hydrochloride Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Terbinafine Hydrochloride Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2019-2024)
Table 53. Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2025-2030)
Table 54. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Type (2019-2024)
Table 59. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Type (2025-2030)
Table 60. Global Terbinafine Hydrochloride Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Terbinafine Hydrochloride Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2019-2024)
Table 63. Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2025-2030)
Table 64. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Application (2019-2024)
Table 69. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Application (2025-2030)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Novartis Terbinafine Hydrochloride Drug Product
Table 74. Novartis Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. GSK Terbinafine Hydrochloride Drug Product
Table 79. GSK Recent Developments/Updates
Table 80. TEVA Corporation Information
Table 81. TEVA Description and Business Overview
Table 82. TEVA Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. TEVA Terbinafine Hydrochloride Drug Product
Table 84. TEVA Recent Developments/Updates
Table 85. Dr. Reddy's Laboratories Corporation Information
Table 86. Dr. Reddy's Laboratories Description and Business Overview
Table 87. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product
Table 89. Dr. Reddy's Laboratories Recent Developments/Updates
Table 90. CIPLA LTD Corporation Information
Table 91. CIPLA LTD Description and Business Overview
Table 92. CIPLA LTD Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. CIPLA LTD Terbinafine Hydrochloride Drug Product
Table 94. CIPLA LTD Recent Developments/Updates
Table 95. TARO Corporation Information
Table 96. TARO Description and Business Overview
Table 97. TARO Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. TARO Terbinafine Hydrochloride Drug Product
Table 99. TARO Recent Developments/Updates
Table 100. InvaGen Pharmaceuticals Corporation Information
Table 101. InvaGen Pharmaceuticals Description and Business Overview
Table 102. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product
Table 104. InvaGen Pharmaceuticals Recent Developments/Updates
Table 105. Breckenridge Pharmaceutical Corporation Information
Table 106. Breckenridge Pharmaceutical Description and Business Overview
Table 107. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product
Table 109. Breckenridge Pharmaceutical Recent Developments/Updates
Table 110. Harris Pharmaceutical Corporation Information
Table 111. Harris Pharmaceutical Description and Business Overview
Table 112. Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Harris Pharmaceutical Terbinafine Hydrochloride Drug Product
Table 114. Harris Pharmaceutical Recent Developments/Updates
Table 115. Glenmark Corporation Information
Table 116. Glenmark Description and Business Overview
Table 117. Glenmark Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Glenmark Terbinafine Hydrochloride Drug Product
Table 119. Glenmark Recent Developments/Updates
Table 120. Orchid Healthcare Corporation Information
Table 121. Orchid Healthcare Description and Business Overview
Table 122. Orchid Healthcare Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Orchid Healthcare Terbinafine Hydrochloride Drug Product
Table 124. Orchid Healthcare Recent Developments/Updates
Table 125. APOTEX Corporation Information
Table 126. APOTEX Description and Business Overview
Table 127. APOTEX Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. APOTEX Terbinafine Hydrochloride Drug Product
Table 129. APOTEX Recent Developments/Updates
Table 130. Jilin Wantong Group Corporation Information
Table 131. Jilin Wantong Group Description and Business Overview
Table 132. Jilin Wantong Group Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Jilin Wantong Group Terbinafine Hydrochloride Drug Product
Table 134. Jilin Wantong Group Recent Developments/Updates
Table 135. Cussess Corporation Information
Table 136. Cussess Description and Business Overview
Table 137. Cussess Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Cussess Terbinafine Hydrochloride Drug Product
Table 139. Cussess Recent Developments/Updates
Table 140. Hubei Hengan Fulin Pharm Corporation Information
Table 141. Hubei Hengan Fulin Pharm Description and Business Overview
Table 142. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product
Table 144. Hubei Hengan Fulin Pharm Recent Developments/Updates
Table 145. Xiuzheng Pharmaceutical Corporation Information
Table 146. Xiuzheng Pharmaceutical Description and Business Overview
Table 147. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product
Table 149. Xiuzheng Pharmaceutical Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Terbinafine Hydrochloride Drug Distributors List
Table 153. Terbinafine Hydrochloride Drug Customers List
Table 154. Terbinafine Hydrochloride Drug Market Trends
Table 155. Terbinafine Hydrochloride Drug Market Drivers
Table 156. Terbinafine Hydrochloride Drug Market Challenges
Table 157. Terbinafine Hydrochloride Drug Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Terbinafine Hydrochloride Drug
Figure 2. Global Terbinafine Hydrochloride Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Terbinafine Hydrochloride Drug Market Share by Type in 2023 & 2030
Figure 4. Topical Product Picture
Figure 5. Oral Product Picture
Figure 6. Global Terbinafine Hydrochloride Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Terbinafine Hydrochloride Drug Market Share by Application in 2023 & 2030
Figure 8. Fingernail Infection
Figure 9. Toenail Infection
Figure 10. Others
Figure 11. Global Terbinafine Hydrochloride Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Terbinafine Hydrochloride Drug Market Size (2019-2030) & (US$ Million)
Figure 13. Global Terbinafine Hydrochloride Drug Sales (2019-2030) & (K Units)
Figure 14. Global Terbinafine Hydrochloride Drug Average Price (USD/Unit) & (2019-2030)
Figure 15. Terbinafine Hydrochloride Drug Report Years Considered
Figure 16. Terbinafine Hydrochloride Drug Sales Share by Manufacturers in 2023
Figure 17. Global Terbinafine Hydrochloride Drug Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Terbinafine Hydrochloride Drug Players: Market Share by Revenue in 2023
Figure 19. Terbinafine Hydrochloride Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Terbinafine Hydrochloride Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Terbinafine Hydrochloride Drug Sales Market Share by Country (2019-2030)
Figure 22. North America Terbinafine Hydrochloride Drug Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Terbinafine Hydrochloride Drug Sales Market Share by Country (2019-2030)
Figure 26. Europe Terbinafine Hydrochloride Drug Revenue Market Share by Country (2019-2030)
Figure 27. Germany Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Terbinafine Hydrochloride Drug Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Terbinafine Hydrochloride Drug Revenue Market Share by Region (2019-2030)
Figure 34. China Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Terbinafine Hydrochloride Drug Sales Market Share by Country (2019-2030)
Figure 45. Latin America Terbinafine Hydrochloride Drug Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Terbinafine Hydrochloride Drug Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Terbinafine Hydrochloride Drug Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Terbinafine Hydrochloride Drug by Type (2019-2030)
Figure 55. Global Revenue Market Share of Terbinafine Hydrochloride Drug by Type (2019-2030)
Figure 56. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Terbinafine Hydrochloride Drug by Application (2019-2030)
Figure 58. Global Revenue Market Share of Terbinafine Hydrochloride Drug by Application (2019-2030)
Figure 59. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Application (2019-2030)
Figure 60. Terbinafine Hydrochloride Drug Value Chain
Figure 61. Terbinafine Hydrochloride Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Terbinafine Hydrochloride Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Terbinafine Hydrochloride Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Terbinafine Hydrochloride Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Terbinafine Hydrochloride Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Terbinafine Hydrochloride Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Terbinafine Hydrochloride Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Terbinafine Hydrochloride Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Terbinafine Hydrochloride Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Terbinafine Hydrochloride Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Terbinafine Hydrochloride Drug, Product Type & Application
Table 12. Global Key Manufacturers of Terbinafine Hydrochloride Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Terbinafine Hydrochloride Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Terbinafine Hydrochloride Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Terbinafine Hydrochloride Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Terbinafine Hydrochloride Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2019-2024)
Table 19. Global Terbinafine Hydrochloride Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2025-2030)
Table 21. Global Terbinafine Hydrochloride Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Terbinafine Hydrochloride Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Terbinafine Hydrochloride Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Terbinafine Hydrochloride Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Terbinafine Hydrochloride Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Terbinafine Hydrochloride Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Terbinafine Hydrochloride Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Terbinafine Hydrochloride Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Terbinafine Hydrochloride Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Terbinafine Hydrochloride Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Terbinafine Hydrochloride Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Terbinafine Hydrochloride Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Terbinafine Hydrochloride Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Terbinafine Hydrochloride Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Terbinafine Hydrochloride Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Terbinafine Hydrochloride Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Terbinafine Hydrochloride Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Terbinafine Hydrochloride Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Terbinafine Hydrochloride Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Terbinafine Hydrochloride Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Terbinafine Hydrochloride Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Terbinafine Hydrochloride Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Terbinafine Hydrochloride Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Terbinafine Hydrochloride Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Terbinafine Hydrochloride Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Terbinafine Hydrochloride Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2019-2024)
Table 53. Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2025-2030)
Table 54. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Type (2019-2024)
Table 59. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Type (2025-2030)
Table 60. Global Terbinafine Hydrochloride Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Terbinafine Hydrochloride Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2019-2024)
Table 63. Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2025-2030)
Table 64. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Application (2019-2024)
Table 69. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Application (2025-2030)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Novartis Terbinafine Hydrochloride Drug Product
Table 74. Novartis Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. GSK Terbinafine Hydrochloride Drug Product
Table 79. GSK Recent Developments/Updates
Table 80. TEVA Corporation Information
Table 81. TEVA Description and Business Overview
Table 82. TEVA Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. TEVA Terbinafine Hydrochloride Drug Product
Table 84. TEVA Recent Developments/Updates
Table 85. Dr. Reddy's Laboratories Corporation Information
Table 86. Dr. Reddy's Laboratories Description and Business Overview
Table 87. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product
Table 89. Dr. Reddy's Laboratories Recent Developments/Updates
Table 90. CIPLA LTD Corporation Information
Table 91. CIPLA LTD Description and Business Overview
Table 92. CIPLA LTD Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. CIPLA LTD Terbinafine Hydrochloride Drug Product
Table 94. CIPLA LTD Recent Developments/Updates
Table 95. TARO Corporation Information
Table 96. TARO Description and Business Overview
Table 97. TARO Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. TARO Terbinafine Hydrochloride Drug Product
Table 99. TARO Recent Developments/Updates
Table 100. InvaGen Pharmaceuticals Corporation Information
Table 101. InvaGen Pharmaceuticals Description and Business Overview
Table 102. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product
Table 104. InvaGen Pharmaceuticals Recent Developments/Updates
Table 105. Breckenridge Pharmaceutical Corporation Information
Table 106. Breckenridge Pharmaceutical Description and Business Overview
Table 107. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product
Table 109. Breckenridge Pharmaceutical Recent Developments/Updates
Table 110. Harris Pharmaceutical Corporation Information
Table 111. Harris Pharmaceutical Description and Business Overview
Table 112. Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Harris Pharmaceutical Terbinafine Hydrochloride Drug Product
Table 114. Harris Pharmaceutical Recent Developments/Updates
Table 115. Glenmark Corporation Information
Table 116. Glenmark Description and Business Overview
Table 117. Glenmark Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Glenmark Terbinafine Hydrochloride Drug Product
Table 119. Glenmark Recent Developments/Updates
Table 120. Orchid Healthcare Corporation Information
Table 121. Orchid Healthcare Description and Business Overview
Table 122. Orchid Healthcare Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Orchid Healthcare Terbinafine Hydrochloride Drug Product
Table 124. Orchid Healthcare Recent Developments/Updates
Table 125. APOTEX Corporation Information
Table 126. APOTEX Description and Business Overview
Table 127. APOTEX Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. APOTEX Terbinafine Hydrochloride Drug Product
Table 129. APOTEX Recent Developments/Updates
Table 130. Jilin Wantong Group Corporation Information
Table 131. Jilin Wantong Group Description and Business Overview
Table 132. Jilin Wantong Group Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Jilin Wantong Group Terbinafine Hydrochloride Drug Product
Table 134. Jilin Wantong Group Recent Developments/Updates
Table 135. Cussess Corporation Information
Table 136. Cussess Description and Business Overview
Table 137. Cussess Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Cussess Terbinafine Hydrochloride Drug Product
Table 139. Cussess Recent Developments/Updates
Table 140. Hubei Hengan Fulin Pharm Corporation Information
Table 141. Hubei Hengan Fulin Pharm Description and Business Overview
Table 142. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product
Table 144. Hubei Hengan Fulin Pharm Recent Developments/Updates
Table 145. Xiuzheng Pharmaceutical Corporation Information
Table 146. Xiuzheng Pharmaceutical Description and Business Overview
Table 147. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product
Table 149. Xiuzheng Pharmaceutical Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Terbinafine Hydrochloride Drug Distributors List
Table 153. Terbinafine Hydrochloride Drug Customers List
Table 154. Terbinafine Hydrochloride Drug Market Trends
Table 155. Terbinafine Hydrochloride Drug Market Drivers
Table 156. Terbinafine Hydrochloride Drug Market Challenges
Table 157. Terbinafine Hydrochloride Drug Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Terbinafine Hydrochloride Drug
Figure 2. Global Terbinafine Hydrochloride Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Terbinafine Hydrochloride Drug Market Share by Type in 2023 & 2030
Figure 4. Topical Product Picture
Figure 5. Oral Product Picture
Figure 6. Global Terbinafine Hydrochloride Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Terbinafine Hydrochloride Drug Market Share by Application in 2023 & 2030
Figure 8. Fingernail Infection
Figure 9. Toenail Infection
Figure 10. Others
Figure 11. Global Terbinafine Hydrochloride Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Terbinafine Hydrochloride Drug Market Size (2019-2030) & (US$ Million)
Figure 13. Global Terbinafine Hydrochloride Drug Sales (2019-2030) & (K Units)
Figure 14. Global Terbinafine Hydrochloride Drug Average Price (USD/Unit) & (2019-2030)
Figure 15. Terbinafine Hydrochloride Drug Report Years Considered
Figure 16. Terbinafine Hydrochloride Drug Sales Share by Manufacturers in 2023
Figure 17. Global Terbinafine Hydrochloride Drug Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Terbinafine Hydrochloride Drug Players: Market Share by Revenue in 2023
Figure 19. Terbinafine Hydrochloride Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Terbinafine Hydrochloride Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Terbinafine Hydrochloride Drug Sales Market Share by Country (2019-2030)
Figure 22. North America Terbinafine Hydrochloride Drug Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Terbinafine Hydrochloride Drug Sales Market Share by Country (2019-2030)
Figure 26. Europe Terbinafine Hydrochloride Drug Revenue Market Share by Country (2019-2030)
Figure 27. Germany Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Terbinafine Hydrochloride Drug Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Terbinafine Hydrochloride Drug Revenue Market Share by Region (2019-2030)
Figure 34. China Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Terbinafine Hydrochloride Drug Sales Market Share by Country (2019-2030)
Figure 45. Latin America Terbinafine Hydrochloride Drug Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Terbinafine Hydrochloride Drug Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Terbinafine Hydrochloride Drug Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Terbinafine Hydrochloride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Terbinafine Hydrochloride Drug by Type (2019-2030)
Figure 55. Global Revenue Market Share of Terbinafine Hydrochloride Drug by Type (2019-2030)
Figure 56. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Terbinafine Hydrochloride Drug by Application (2019-2030)
Figure 58. Global Revenue Market Share of Terbinafine Hydrochloride Drug by Application (2019-2030)
Figure 59. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Application (2019-2030)
Figure 60. Terbinafine Hydrochloride Drug Value Chain
Figure 61. Terbinafine Hydrochloride Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232